BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
1-Year Return
63.34%
This Quarter Return
+28.43%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$15.2B
AUM Growth
+$1.87B
(+14%)
Cap. Flow
+$203M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
84.66%
Holding
127
New
12
Increased
14
Reduced
21
Closed
27
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$185M |
| 2 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$52.2M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$25.1M |
| 4 |
Insmed
INSM
|
$23.3M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$12.9M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$20.5M |
| 2 |
PHXM
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
|
$17.1M |
| 3 |
Halozyme
HALO
|
$15.2M |
| 4 |
Exelixis
EXEL
|
$11M |
| 5 |
Xencor
XNCR
|
$10.5M |
Sector Composition
| 1 | Healthcare | 91.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
26
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $52.2M | 0.34% |
+1,787,807
| New | +$52.2M |
|
|
TCDA
27
DELISTED
Tricida, Inc. Common Stock
TCDA
| $48.9M | 0.32% |
1,600,000
| – | – |
|
|
ECYT
28
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $45.3M | 0.3% |
2,548,069
+270,270
| +12% | +$4.8M |
|
|
ACGN
29
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $43.1M | 0.28% |
284,631
+120
| +0% | +$18.2K |
|
|
30
Insmed
INSM
$30.1B
| $37.4M | 0.25% |
1,851,982
+1,151,982
| +165% | +$23.3M |
|
31
Neurogene
NGNE
$281M
| $32M | 0.21% |
546,708
| – | – |
|
32
Abeona Therapeutics
ABEO
$354M
| $28M | 0.18% |
87,375
| – | – |
|
33
Solid Biosciences
SLDB
$429M
| $27.7M | 0.18% |
39,192
| – | – |
|
34
Galapagos
GLPG
$2.04B
| $26.7M | 0.18% |
237,191
-22,703
| -9% | -$2.55M |
|
|
35
Xencor
XNCR
$576M
| $23.5M | 0.15% |
602,495
-269,577
| -31% | -$10.5M |
|
|
MYOK
36
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $23.3M | 0.15% |
357,215
-75,906
| -18% | -$4.95M |
|
37
Merus
MRUS
$5B
| $22.9M | 0.15% |
1,160,014
| – | – |
|
38
uniQure
QURE
$949M
| $22M | 0.15% |
605,000
| – | – |
|
39
Sangamo Therapeutics
SGMO
$148M
| $21.8M | 0.14% |
1,283,923
| – | – |
|
|
CMTA
40
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $21.6M | 0.14% |
1,933,624
+741,029
| +62% | +$8.26M |
|
41
Zymeworks
ZYME
$1.09B
| $20.6M | 0.14% |
1,311,085
| – | – |
|
|
AIMT
42
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $18.4M | 0.12% |
673,908
| – | – |
|
|
BLCM
43
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $16.5M | 0.11% |
267,782
-141,563
| -35% | -$8.72M |
|
|
BOLD
44
DELISTED
Audentes Therapeutics, Inc
BOLD
| $15.6M | 0.1% |
393,222
| – | – |
|
|
CFRX
45
DELISTED
ContraFect Corporation
CFRX
| $14.8M | 0.1% |
8,941
| – | – |
|
46
Spyre Therapeutics
SYRE
$980M
| $13.3M | 0.09% |
55,515
| – | – |
|
47
AnaptysBio
ANAB
$641M
| $11.3M | 0.07% |
113,086
+40,000
| +55% | +$3.99M |
|
48
Catalyst Pharmaceutical
CPRX
$2.37B
| $11M | 0.07% |
2,900,000
-721,962
| -20% | -$2.73M |
|
|
PHXM
49
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $9.31M | 0.06% |
108,597
-200,000
| -65% | -$17.1M |
|
50
Novavax
NVAX
$1.18B
| $8.87M | 0.06% |
+235,916
| New | +$8.87M |
|